Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)

Authors

  • Sadikova N.G Tashkent medical academy, Tashkent Uzbekistan
  • Najmutdinova D. K Tashkent medical academy, Tashkent Uzbekistan.
  • Urunbayeva D. A Tashkent medical academy, Tashkent Uzbekistan.
  • Alimova S. E Tashkent medical academy, Tashkent Uzbekistan.
  • Tillaboyev Sh.Sh Tashkent medical academy, Tashkent Uzbekistan

Keywords:

SGLT-2ingibitors, Diabetes Mellitus

Abstract

Study of the effect of SGLT-2ingibitors on kidney function in Diabetes Mellitus Type 2 patients

Downloads

Published

2023-11-06

Issue

Vol. 26 (2023): EJRDI

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). (2023). Eurasian Journal of Research, Development and Innovation, 26, 1-4. https://geniusjournals.org/index.php/ejrdi/article/view/5178